PAST INVESTMENTS
Infarmasa
Industry Pharmaceutics Description On August, 2007, ALTRA and asset management firm The Rohatyn Group (TRG) acquired a controlling stake in Infarmasa, one of the largest independently-owned branded generic pharmaceutical manufacturing companies in Perú. ALTRA and TRG actively supported Infarmasa's growth strategy, which included consolidating its leading market position in Peru, expanding its product mix, launching new business lines, developing new export markets, optimizing its capital structure, and strengthening its corporate governance model. On January 2011, ALTRA and TRG sold their entire stake in Infarmasa to Teva Pharmaceutical Industries Ltd (Nasdaq: TEVA), a leading global pharmaceutical company headquartered in Israel and with direct presence in over 50 countries. ALTRA acted as lead investor in this transaction. Investment period August 2007 / January 2016 Geographical presence Peru
 Countries of Operations
Infarmasa